Derbyshire Medicines Management and Clinical Policies
DO NOT PRESCRIBE (DNP): NICE TA 348: for preventing organ rejection in liver transplant - negative appraisal (Decision date - August 2015)
RED: NICE TA421: Everolimus with examestane for treating advanced breast cancer after endocrine therapy. (Decision date - January 2017)
RED: NICE TA449: Everolimus and sunitinib for treating unresectable or metastatic neuroendocrine tumours in people with progressive disease. (Decision date - July 2017)
